We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

322:HKEXTingyi (Cayman Islands) Holding Corp. Analysis

Data as of 2026-06-14 - not real-time

₩5,450.00

Latest Price

8/10Risk

Risk Level: High

Executive Summary

LS THiRA‑UTECH is trading close to its identified support level, suggesting limited downside cushion. The short‑term moving average sits below the medium‑term average, reinforcing a neutral‑to‑bearish bias. RSI is in the oversold region, hinting at possible short‑term rebound but not confirming strength. MACD shows a bearish divergence with the signal line, adding momentum pressure. Volatility remains elevated, reflecting wide price swings in recent weeks. The stock’s beta is modest, indicating less correlation with broader market moves. The fear‑greed sentiment is at extreme greed, which may be a contrarian warning.
Fundamentally, the company reports negative operating margins and cash flow, raising concerns about profitability. Debt relative to equity is high, and the balance sheet shows more liabilities than assets. No earnings per share are reported, resulting in a zero price‑earnings multiple and limiting valuation anchors. The price‑to‑sales ratio is modest, but without earnings the metric offers limited insight. Dividend policy is nonexistent, removing income appeal. Analyst coverage is absent, leaving investors without third‑party guidance. Given these factors, the outlook leans toward caution despite the technical oversold signal.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 9/10

Key Factors

  • price near support
  • bearish MACD momentum
  • negative cash flow

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • ongoing restructuring efforts
  • potential market recovery
  • still lack of earnings

Long Term

> 3 years
Positive
Model confidence: 5/10

Key Factors

  • industry tailwinds in smart manufacturing
  • strategic partnership opportunities
  • possibility of balance sheet improvement

Key Metrics & Analysis

Financial Health

Revenue Growth15.40%
Profit Margin-12.87%
ROE-18.95%
ROA-2.73%
Debt/Equity10.82
Op. Cash Flow₩-3337751296
Free Cash Flow₩-2942529024
Industry P/E36.8

Technical Analysis

TrendNeutral
RSI29.7
Support₩5,100.00
Resistance₩9,080.00
MA 20₩6,725.50
MA 50₩7,658.20
MA 200₩7,282.48
MACDBearish
VolumeDecreasing
Fear & Greed Index89.86

Valuation

GradeOvervalued
TypeValue

Risk Assessment

Beta0.56
Volatility76.08%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.